Literature DB >> 24581495

Hsp90-Tau complex reveals molecular basis for specificity in chaperone action.

G Elif Karagöz1, Afonso M S Duarte2, Elias Akoury3, Hans Ippel4, Jacek Biernat5, Tania Morán Luengo6, Martina Radli6, Tatiana Didenko6, Bryce A Nordhues7, Dmitry B Veprintsev8, Chad A Dickey7, Eckhard Mandelkow9, Markus Zweckstetter10, Rolf Boelens11, Tobias Madl12, Stefan G D Rüdiger13.   

Abstract

Protein folding in the cell relies on the orchestrated action of conserved families of molecular chaperones, the Hsp70 and Hsp90 systems. Hsp70 acts early and Hsp90 late in the folding path, yet the molecular basis of this timing is enigmatic, mainly because the substrate specificity of Hsp90 is poorly understood. Here, we obtained a structural model of Hsp90 in complex with its natural disease-associated substrate, the intrinsically disordered Tau protein. Hsp90 binds to a broad region in Tau that includes the aggregation-prone repeats. Complementarily, a 106-Å-long substrate-binding interface in Hsp90 enables many low-affinity contacts. This allows recognition of scattered hydrophobic residues in late folding intermediates that remain after early burial of the Hsp70 sites. Our model resolves the paradox of how Hsp90 specifically selects for late folding intermediates but also for some intrinsically disordered proteins-through the eyes of Hsp90 they look the same.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24581495      PMCID: PMC4263503          DOI: 10.1016/j.cell.2014.01.037

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  66 in total

Review 1.  Mapping protein-protein interactions in solution by NMR spectroscopy.

Authors:  Erik R P Zuiderweg
Journal:  Biochemistry       Date:  2002-01-08       Impact factor: 3.162

Review 2.  Structure and mechanism of the Hsp90 molecular chaperone machinery.

Authors:  Laurence H Pearl; Chrisostomos Prodromou
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

3.  Global rigid body modeling of macromolecular complexes against small-angle scattering data.

Authors:  Maxim V Petoukhov; Dmitri I Svergun
Journal:  Biophys J       Date:  2005-05-27       Impact factor: 4.033

Review 4.  Molecular chaperones in protein folding and proteostasis.

Authors:  F Ulrich Hartl; Andreas Bracher; Manajit Hayer-Hartl
Journal:  Nature       Date:  2011-07-20       Impact factor: 49.962

5.  Structural memory of natively unfolded tau protein detected by small-angle X-ray scattering.

Authors:  Alexander V Shkumatov; Subashchandrabose Chinnathambi; Eckhard Mandelkow; Dmitri I Svergun
Journal:  Proteins       Date:  2011-05-10

Review 6.  Hsp90 structure and function studied by NMR spectroscopy.

Authors:  Tatiana Didenko; Afonso M S Duarte; G Elif Karagöz; Stefan G D Rüdiger
Journal:  Biochim Biophys Acta       Date:  2011-12-06

7.  Structural and functional analysis of the middle segment of hsp90: implications for ATP hydrolysis and client protein and cochaperone interactions.

Authors:  Philippe Meyer; Chrisostomos Prodromou; Bin Hu; Cara Vaughan; S Mark Roe; Barry Panaretou; Peter W Piper; Laurence H Pearl
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

8.  Analysis of the tau-associated proteome reveals that exchange of Hsp70 for Hsp90 is involved in tau degradation.

Authors:  Andrea D Thompson; K Matthew Scaglione; John Prensner; Anne T Gillies; Arul Chinnaiyan; Henry L Paulson; Umesh K Jinwal; Chad A Dickey; Jason E Gestwicki
Journal:  ACS Chem Biol       Date:  2012-07-25       Impact factor: 5.100

9.  Substrate binding drives large-scale conformational changes in the Hsp90 molecular chaperone.

Authors:  Timothy O Street; Laura A Lavery; David A Agard
Journal:  Mol Cell       Date:  2011-04-08       Impact factor: 17.970

Review 10.  Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility.

Authors:  Pablo C Echeverria; Didier Picard
Journal:  Biochim Biophys Acta       Date:  2009-12-16
View more
  109 in total

Review 1.  HSP90AB1: Helping the good and the bad.

Authors:  Michael Haase; Guido Fitze
Journal:  Gene       Date:  2015-09-07       Impact factor: 3.688

2.  Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network.

Authors:  Anan Yu; Susan G Fox; Annalisa Cavallini; Caroline Kerridge; Michael J O'Neill; Joanna Wolak; Suchira Bose; Richard I Morimoto
Journal:  J Biol Chem       Date:  2019-04-01       Impact factor: 5.157

Review 3.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

Review 4.  Therapeutic Strategies for Restoring Tau Homeostasis.

Authors:  Zapporah T Young; Sue Ann Mok; Jason E Gestwicki
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

Review 5.  Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.

Authors:  Tessa Sinnige; Anan Yu; Richard I Morimoto
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  The Yeast Hsp70 Cochaperone Ydj1 Regulates Functional Distinction of Ssa Hsp70s in the Hsp90 Chaperoning Pathway.

Authors:  Deepika Gaur; Prashant Singh; Jyoti Guleria; Arpit Gupta; Satinderdeep Kaur; Deepak Sharma
Journal:  Genetics       Date:  2020-04-16       Impact factor: 4.562

Review 7.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 8.  Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.

Authors:  Mansi R Khanna; Jane Kovalevich; Virginia M-Y Lee; John Q Trojanowski; Kurt R Brunden
Journal:  Alzheimers Dement       Date:  2016-10       Impact factor: 21.566

9.  Tau phosphorylation at Alzheimer's disease-related Ser356 contributes to tau stabilization when PAR-1/MARK activity is elevated.

Authors:  Kanae Ando; Mikiko Oka; Yosuke Ohtake; Motoki Hayashishita; Sawako Shimizu; Shin-Ichi Hisanaga; Koichi M Iijima
Journal:  Biochem Biophys Res Commun       Date:  2016-08-09       Impact factor: 3.575

10.  Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease.

Authors:  Michael C Pace; Guilian Xu; Susan Fromholt; John Howard; Keith Crosby; Benoit I Giasson; Jada Lewis; David R Borchelt
Journal:  Acta Neuropathol       Date:  2018-08-23       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.